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ABSTRACT 
Background & Objectives : 
Stroke is a life threatening neurological disorder. Identification of 
predictors of mortality is vital so that prompt therapeutic measures can be 
instituted to improve outcome. Animal studies have shown 
neuroprotective effect of albumin in ischemic stroke. But this has not 
been studied well enough in humans to recommend supplementation of 
albumin as a therapeutic measure in stroke. The objective of this study is 
to determine the association between the serum albumin at admission and 
the stroke severity as well as functional outcome at 7days. 
Methods : 
The study was done over a period of 6 months and included 100 
subjects with first ever stroke which was proved to be ischemic by CT 
Brain. After a detailed history and clinical examination, lab investigations 
including serum albumin were sent. Patients with history of previous 
stroke and those with conditions predisposing to hypoalbuminemia were 
excluded from the study. The severity of stroke was measured using 
Scandinavian Stroke Scale and the functional status at 7days was assessed 
using modified Rankin scale. Statistical analysis was done to determine 
  
the association between serum albumin and stroke severity as well as 
functional outcome and to find out the correlation between these. 
Results :  
 There was no significant variation in serum albumin with age and 
sex. There was definite association between serum albumin at admission 
and the severity of stroke. There was negative correlation between serum 
albumin value and the MRS score thereby indicating better outcome with 
higher albumin level. So the study concludes that higher the serum 
albumin, lesser the stroke severity and better the prognosis.  
Key words:  
 Serum albumin, Ischemic stroke, outcome, nutrition 
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INTRODUCTION 
    Stroke or cerebrovascular accident is a life threatening neurological 
disorder. It constitutes more than 50% of admissions in a hospital. It has 
been estimated that by the year 2020, stroke will emerge as the second 
leading cause of morbidity and mortality in developed countries. 
Westernization of lifestyle and the resulting demographic transition might 
increase the burden of stroke in developing countries as well.   
 Early mortality from stroke is mostly directly related to stroke. 
Complications affect mortality only later in the course. Previous studies 
have thrown light on the various risk factors of stroke as well as the 
factors which influence mortality, some of which may serve as predictors 
of mortality. Stroke severity, type of stroke, increased age, level of 
consciousness etc. are few of them. But most of these are non-modifiable 
and hence of limited value in clinical practice. Identification of predictors 
of mortality, especially, modifiable ones, is vital so that prompt 
therapeutic measures can be instituted to improve outcome. 
                     Albumin is a multifunctional protein which has been proven 
to have neuroprotective effects in animal studies. Albumin is also an 
indicator of the nutritional status. This fact holds importance, as, out of  
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15 million stroke events occurring annually all over the world, two third 
occurs in low income and middle income developing countries, where 
malnutrition is rampant. 
 There have been several studies in the western world including 
interventional studies trying to explore the scope of albumin as a 
neuroprotective agent. Some of these have shown that albumin therapy is 
capable of  minimizing infarction volume and cerebral oedema. Albumin 
reduces hematocrit as well as erythrocyte sedimentation rate by its affects 
on erythrocyte aggregation. Effect of albumin is mainly in the early 
reperfusion phase of acute ischemic stroke where it exerts an inhibitory 
effect on stagnation, thrombosis and leucocyte adhesion in 
microcirculation.  
 There is very little data from our part of the world regarding the 
role of albumin in ischemic stroke. Through my study, I intend to 
determine the association, if any, between serum albumin and the severity  
as well as the short term outcome of acute ischemic stroke. The study has 
been undertaken with the foresight that if the association can be proven 
beyond doubt, it may be possible to institute corrective measures in order 
to improve the prognosis of the disease. 
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AIMS & OBJECTIVES 
1. To measure the stroke severity at admission using Scandinavian 
Stroke Scale. 
2. To assess the functional outcome of ischemic stroke on day 7 using 
Modified Rankin Scale. 
3. To find out the association between serum albumin at admission 
and the functional outcome of ischemic stroke. 
4. To find out the correlation between serum albumin level and 
severity of ischemic stroke. 
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REVIEW  OF  LITERATURE 
                 Stroke is one disease that has revolutionised the field of 
neuromedicine. No other disease has contributed to our present 
understanding of brain like stroke.  Human brain is the most complex 
structure known, composed of 100 billion neurons forming trillions of 
connections with other brain cells
1
. The integrity of these connections is 
inevitable for the integrative power of the brain. There are a thousand 
different symptoms that can occur following a stroke depending on the 
part of the brain and the blood vessel involved
2
. The devastating 
disability that results is mainly due to the inherent inability of the brain 
cells to regenerate. The patterns of neurological deficits that manifest 
when a particular area of the brain is affected was noted by physicians 
centuries ago. But it took years of clinical observation supported by 
advances in neurophysiology and imaging to reach the present stage. So 
literally, generations of neurologists have learnt the brain, stroke by 
stroke
3
.            
A  GLIMPSE  OF  HISTORY 
 Hippocrates, the Father of Medicine, first identified stroke over 
2400 years ago. Term ‘Apoplexia’ was used by Greeks to denote a 
disease where the patient falls to the ground without sense or voluntary 
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motion. Victims were referred to as ‘Attoniti’ (Latin, meaning 
thunderstruck)
4
 or ‘Syderati’ ( meaning planet struck)
5
. Doctors then had 
little knowledge of the anatomy and function of brain, the cause of this 
phenomenon or how to treat it. 
Supernatural Theory 
• Apoplexy was thought to be supernatural. Affected persons were 
thought to be struck with an invisible power and was referred to as 
‘dreadful visitation’.
6
 
Humoral Theory 
• Of the four humours, Hippocrates considered blood as the one that 
contained spirit/ vitality . Apoplexy was thought to be due to 
stagnation/ station of blood
7
. 
• Galen also accepted the theory of Hippocrates. According to him, 
apoplexy was caused by interference to flow of the ‘vital spirit’ to 
the brain
8
.  
• Bloodletting was practiced as a treatment of apoplexy. 
• Robinson suggested that bleeding was useful to decrease the 
Plethora and relieve the pressure on animal organs. But in case of 
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‘Phlegmatick Apoplexy’  in which there are features of blood 
impoverishment, bleeding could kill than save
9
. 
• By nineteenth century, when the concept of blood pressure was 
accepted, measures to decrease arterial blood pressure as a 
treatment of apoplexy  were discussed and venesection was thought 
to rapidly and effectively achieve this. This practice was 
discontinued only after it was published in ‘Osler’s Principles and 
Practice Of Medicine’ that venesection was not beneficial in 
practice and may even be deleterious
10
. 
• The concept of Apoplectic habitus is comparable to the modern 
concept of obese habitus in individuals susceptible to 
cardiovascular disease
11
. 
 In mid 1600’s, Jacob Webfer found that patients who died of 
apoplexy had either bled in the brain or had occlusion of one of the 
cerebral blood vessels
12
. 
            In 1928, apoplexy was classified based on the nature of blood 
vessel affection and the new terminology- ‘stroke’ / ‘cerebrovascular 
accident’ came into use. 
  
7 
 
 Stroke is now often referred to as Brain Attack due to the 
resemblance in basic pathology to heart attack. The purpose of the new 
term is to alert the layman regarding the need for urgent attention.   
RELEVANT  ANATOMY 
 All the arteries supplying the brain are branches of the  
brachiocephalic arteries arising from the aorta. The common carotid 
arteries of both sides ascend the anterior neck and bifurcate at the level of 
the angle of mandible forming internal and external carotid arteries. The 
Internal Carotid Artery with its tributaries, the Middle cerebral 
Artery(MCA) and the Anterior Cerebral Artery (ACA)  forms the anterior 
circulation which perfuses the entire frontal and parietal lobes and most 
part of temporal lobes
13
. 
 Posterior circulation ( Vertebrobasilar system) is formed  from the 
right and left vertebral arteries which are branches of the subclavian 
artery arising from the aorta. They ascend within the vertebral foramen 
and loop over the transverse process of C1 vertebra and enter the skull via 
foramen magnum. They join to form basilar artery at the level of pons. 
Basilar artery bifurcates at the level of midbrain forming the right and left 
posterior cerebral arteries. The Vertebrobasilar system with its 
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perforating branches perfuses the brainstem, cerebellum, thalamus, 
occipital lobe and part of temporal lobe
13
.      
 At the base of brain, the major arteries meet to form the Circle Of 
Willis where the Anterior Cerebral Artery and the Middle Cerebral Artery 
are linked to the Posterior Cerebral Artery by Anterior and Posterior 
Communicating arteries. This anastomosis forms the communication 
between the anterior and posterior circulations and between the right and 
left sides of the brain
14
. 
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Figure 1: Cerebral Circulation 
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Fig 2 : Cortical vascular territories- lateral aspect 
 
Fig 3: Cortical Vascular Territories- medial aspect 
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Figure 4: Areas of brain- lateral aspect 
 
Figure 5: Areas of brain- medial aspect 
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WHO DEFINITION OF STROKE  
 Rapidly developing clinical symptoms or signs of focal or global 
loss of cerebral function with symptoms lasting for more than 24hrs or 
leading to death with no apparent cause other than that of vascular origin. 
 
 
  
Chart 1: Types of stroke 
  
ISCHEMIC
85%
HEMORRHAGIC
15%
TYPES  OF  STROKE 
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HEMORRHAGIC  STROKE 
Types  
o Subdural /epidural hemorrhage : Produced by trauma 
o Subarachnoid hemorrhage : Due to trauma or rupture of 
intracranial aneurysm 
o Intraparenchymal hemorrhage 
INTRAPARENCHYMAL HEMORRHAGE 
 Most common type : Intracerebral hemorrhage15 
 Causes  
o Hypertension  
o Trauma 
o Cerebral amyloid angiopathy 
o Cocaine and amphetamine use (in young) 
o Coagulopathy 
o AV malformation  
o Metastatic brain tumour 
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ISCHEMIC STROKE 
ETIOLOGY 
 Thrombosis 
o Large vessel thrombosis 
o Lacunar stroke (small vessel) 
o Dehydration  
 Embolic occlusion 
 Artery to artery 
o Carotid bifurcation 
o Aortic arch 
o Arterial dissection 
 Cardioembolic 
o Atrial fibrillation 
o Mural thrombus 
o Myocardial infarction 
o Dilated cardiomyopathy 
o Valvular lesions : Mitral stenosis 
                             Mechanical valve 
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                             Infective endocarditis 
 Paradoxical embolus : Atrial septal defect 
                                    Patent foramen ovale 
 Atrial septal aneurysm 
 Spontaneous echo contrast 
                                           UNCOMMON CAUSES 
 Hypercoagulable disorders 
Protein C deficiency 
Protein S deficiency 
Antithrombin III deficiency 
Antiphospholipid syndrome 
Factor V Leiden mutation          
Prothrombin G20210 mutation 
Systemic malignancy 
Sickle cell anemia 
Thalassemia 
Polycythemia vera 
Systemic lupus erythematosus 
Homocysteinemia 
Thrombotic thrombocytopenic purpura 
Disseminated intravascular coagulation 
Dysproteinemias 
 Vasculitis 
Systemic vasculitis [PAN, 
 granulomatosis with polyangiitis 
 (Wegener's), Takayasu's, giant cell 
 arteritis] 
Primary CNS vasculitis 
Meningitis (syphilis, tuberculosis, 
 fungal, bacterial, zoster) 
 Cardiogenic 
Mitral valve calcification 
Atrial myxoma 
Intracardiac tumor 
Marantic endocarditis 
Libman-Sacks endocarditis 
 Subarachnoid hemorrhage 
vasospasm 
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Nephrotic syndrome 
Inflammatory bowel disease 
Oral contraceptives 
 Venous sinus thrombosis 
 Fibromuscular dysplasia 
 Drugs: cocaine, amphetamine 
 Moyamoya disease 
 Eclampsia 
 
Table 1: Uncommon causes of ischemic stroke 
 
PATHOPHYSIOLOGY  OF  ISCHEMIC  STROKE  
CEREBRAL BLOOD FLOW 
• Normal cerebral perfusion is about 50-60ml/100g/min15 
            The effects of brain ischemia are rapid as there is no stored 
glucose and neurons are incapable of anaerobic metabolism. In response 
to ischemia, cerebral autoregulatory mechanisms come into play by local 
vasodilatation, opening of collaterals and increased utilisation of oxygen 
and glucose from blood. 
• A decrease in cerebral perfusion to zero leads to death of brain 
tissue within 4-10minutes.  
• A decrease to less than 10ml/100g/min culminates in irreversible 
neuronal injury 
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• A decrease to less than 16-18ml/100g/min results in infarction 
within an hour 
• When cerebral blood flow decreases to less than 20ml/100g/min, 
an electrical silence ensues with a decrease in synaptic activity in 
an attempt to preserve energy stores. This results in ischemia 
without infarction unless this situation is extended for several hours 
or days
16
. 
                    If reperfusion occurs prior to significant amount of cell 
death, there may be only transient symptoms and this is referred to as 
Transient Ischemic Attack (TIA). The standard definition of TIA 
requires all the neurological signs and symptoms to resolve within 
24hours regardless of whether there is imaging evidence of new 
permanent brain injury
15
.  
           A generalized reduction in cerebral blood flow due to systemic 
hypotension usually causes syncope.  If the low blood flow persists 
longer, infarction develops in the borderzone of major artery territories. 
Severe global hypoxia ischemia causes extensive brain injury referred to 
as Hypoxic Ischemic Encephalopathy
15
.  
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Figure 6 : Mechanism of ischemic injury 
 
Figure 7: Mechanism of ischemic cellular injury 
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FOCAL ISCHEMIC INJURY 
 Vascular occlusion by thrombus or embolus can cause ischemia of 
the affected vascular territory. At gross tissue level, vascular compromise 
causes acute ischemia or infarction which is a dynamic process evolving 
over time. At cellular level, hypoxia causes neuronal injury.  
NEURONAL INJURY 
             Ischemia triggered activation of destructive vasoactive enzymes 
released by endothelium, leucocytes, platelets and other neuronal cells 
promote the formation of microthrombus which occludes the cerebral 
microcirculation
17
. 
 At molecular level, occurrence of hypoxic ischemic neuronal injury 
is mainly influenced by the overaction of neurotransmitters – glutamate 
and aspartate. This process is called excitotoxicity
18
. It is triggered by 
depletion of cellular energy stores. Glutamate is normally stored in 
synaptic terminals. It is cleared from the extracellular space by an energy 
dependent process. Hence in an energy depleted state, there is an higher 
concentration of glutamate and aspartate in the extracellular space. This 
causes the opening of calcium channels associated with N-Methyl-D-
Aspartate (NMDA) and Alpha- Amino-3-Hydroxy-5-Methyl-4-Isoxanole 
propionate (AMPA) receptors. Persistent membrane depolarization 
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results in influx of calcium, sodium and chloride ions and efflux of 
potassium ions
19
. Increased intracellular calcium induces activation of 
several destructive enzymes like proteases, lipases and endonucleases. 
These permit the release of cytokines and other mediators which end up 
destroying the cellular integrity
20
. 
 Inflammatory response to tissue injury is mediated by various 
inflammatory mediators among which Tumour Necrosis Factor is the key 
agent. Leucocyte recruitement to ischemic areas occurs within 30 minutes 
of ischemia and reperfusion. Leucocytes activate vasoactive substances 
like oxygen free radicals, arachidonic acid metabolites (cytokines) and 
nitric acid. These cause vasodilatation, vasoconstriction, more 
permeability, enhanced platelet aggregation, increased leucocyte adhesion 
to the endothelial wall and immunoregulation.  
 First to respond to hypoxia are endothelial cells. The response is 
morphological, biochemical and immunological causing a variety of 
physiological and pharmacological effects. Endothelial cells swell and 
form microvilli on the luminal surface. This causes a narrowing of 
luminal patency of capillary vessels. As a result, mechanical plugging by 
erythrocytes, leucocytes and platelets ensues
21
. 
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 Endothelial cells mediate the effects of vasoactive agents like 
endothelin peptides, eicosanoids and smooth muscle relaxants such as 
nitric acid. These agents alter vascular tone of the microcirculation. The 
key process in the initiation of the inflammatory process, namely 
leucocyte adherence to the   endothelial wall, is brought about by 
activation of endothelial adhesion molecules. 
ISCHEMIC  PENUMBRA 
 Within an hour of hypoxic ischemic insult, an oligemic zone called 
ischemic penumbra develops around a core of infarction, where the 
autoregulation is ineffective. In this area, cellular integrity and some 
amount of energy metabolism is preserved. Neurological deficits due to 
ischemia in this region can be partially or fully reversed by reperfusing 
within a critical time period (2-4hrs) called the Window Of 
Opportunity
22
. 
 Pathophysiology of ischemic penumbra is closely related to 
generation of Spontaneous Waves of Depolarisation (SWD). These are 
multifocal in origin, some arising from the core of infarction, some from 
the penumbra. They are associated with sustained increase in synaptic 
glutamate and extracellular potassium
23
. Hypoxic/ rapid depolarizations 
supervene just before irreversible neuronal death.  
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NEURONAL  DEATH 
Occurs by 2 processes- Coagulation necrosis and Apoptosis 
 Apoptotic mechanisms start within an hour of ischemic injury 
whereas  necrosis sets in about 6hours after arterial occlusion. 
Coagulation Necrosis 
 Rapid breakdown of cellular cytoskeleton principally due to energy 
failure. Attributed to effects of physical, chemical and osmotic damage to 
plasma membrane. Cell initially swells, then shrinks and undergoes 
pyknosis over 6-12hrs. By 24hours, extensive chromolysis occurs 
resulting in pannecrosis. Astrocytes swell and fragment, myelin sheath 
degenerates
16
. 
Apoptosis 
 In this, cells are programmed to die. Nuclear damage is the first to 
occur. Integrity of plasma membrane and mitochondrial membrane are 
preserved till the last. Ischemia causes activation of latent suicide proteins 
in the nucleus which triggers the autolytic processes culminating in cell 
death. This autolytic process is involves DNA cleavage
24
. 
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 Ischemia starves the neuron of glucose and oxygen leading to 
failure of mitochondria to produce ATP. In the absence of ATP, 
membrane ion pumps stop functioning leading to depolarization of 
neurons and increase in intracellular calcium. Cellular depolarization 
causes increased glutamate release from the synaptic terminals. Excess 
glutamate activates postsynaptic glutamate  receptors which enhance 
neuronal calcium influx resulting in neurotoxicity. Free radicals formed 
by membrane lipid degradation and mitochondrial dysfunction result in 
catalytic destruction of the membrane and damage other vital functions of 
the cell.  
Progression and extent of ischemic injury depends on
25 
(i) Rate of progression and onset : Short duration and slow onset 
strokes are better tolerated. 
(ii) Collateral circulation : Good collateral circulation correlates with 
better outcome 
(iii) Health of systemic circulation : Constant cerebral perfusion 
pressure depends on adequate systemic blood pressure 
 (iv) Hematological factors
exacerbation of 
extent of thrombus
(v) Temperature : 
injury 
(vi) Glucose metabolism : Hyperglycemia adversely affects size of 
infarct 
SUBCLASSIFICATION  OF  ISCHEMIC  STROKE
TOAST  CLASSIFICATION
Chart 2: TOAST classification of ischemic stroke
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 LARGE  VESSEL  ATHEROTHROMBOSIS 
Involves both intracranial and extracranial arteries. 
             Atherosclerosis is the most common pathology underlying  
vascular occlusion causing thrombotic stroke
26
. There is formation of 
lipid laden atherosclerotic plaques on the inner wall of a large vessel. 
They form over a prolonged time course with the effect that the brain is 
able to adjust to the gradual reduction in cerebral blood flow
27
. Infarcts 
occur only when a critical level of stenosis is reached. These 
atherosclerotic plaques are susceptible to ulceration, thrombosis, 
calcification and intraplaque hemorrhage and the susceptibility depends 
on its structure, composition and consistency
28
. Depending on the vessels 
involved, location of the lesion within the affected vessel, rapidity of 
development and the presence or absence of anastomoses, it typically 
results in a single large territorial stroke. 
Most common sites : Bifurcation of Common Carotid Artery
29 
                                   Origin of Vertebral artery 
                                   Course of middle cerebral artery prior to bifurcation 
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Risk factors :  Hypertension 
                        Diabetes mellitus 
                        Dyslipidemia  
EMBOLIC STROKE 
• Tend to be sudden in onset with maximum neurological deficit at 
onset 
• Non rheumatic atrial fibrillation is the most common cause of 
cerebral embolism overall, the risk of which is calculated using 
CHADS2 score. 
CARDIOEMBOLIC  STROKE 
 Occur due to embolism of thrombotic material on the atrial, 
ventricular or left heart valves.  
 They usually occur in more than one arterial distribution, mostly 
anterior circulation
30
. 
  Acute strokes involving the right and left anterior circulation are 
considered embolic unless proven otherwise
31
.  
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 The location and extent of the infarct depend on the extent of 
collateral circulation.  
 The most common causes of cardioembolic stroke are 
Nonrheumatic/nonvalvular atrial fibrillation, myocardial infarction, 
prosthetic valves, rheumatic heart disease and ischemic 
cardiomyopathy 
 In Paradoxical embolisation, a venous thrombus migrates into 
arterial circulation through an atrial septal defect or patent foramen 
ovale. 
 Other than venous clot, fat emboli, tumour emboli, bacterial 
endocarditis, intravenous air and amniotic fluid emboli can also 
cause paradoxical embolisation. 
ARTERY TO ARTERY EMBOLIC STROKE 
 Thrombus formed on the wall of  a particular vessel fragments 
and sheds pieces of clots. These are swept downstream and may 
lodge in smaller branches of the large arteries causing multiple 
smaller strokes within the territory of the parent vessel
32
. 
 Most common source of embolus : Carotid bifurcation 
atherosclerosis 
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 Carotid Atherosclerosis 
o Most common sites : Common Carotid bifurcation 
                                   Proximal internal carotid artery 
o Risk factors : Male gender  
                      Old age 
                      Smoking 
                      Hypertension 
                      Diabetes 
                            Hypercholesterolemia 
o Classified based on degree of stenosis and whether stenosis is 
symptomatic or not. 
 Intracranial atherosclerosis : Produces stroke either by insitu 
thrombosis or embolism 
 Dissection of internal carotid or vertebral arteries 
o Trauma 
o Spinal manipulative surgeries 
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o Ehlers- Danlos type 4 
o Marfan’s disease 
o Cystic medial necrosis 
o Fibromuscular dysplasia 
 Neurological outcome of an embolic stroke depends on the affected 
vascular territory and the tendency of the embolus to cause vasospasm by 
acting as a vascular irritant. Vasospasm tends to occur in young patients 
since the vessels are more pliable and less atherosclerotic
33
. 
 Many embolic strokes become hemorrhagic resulting in 
HEMORRHAGIC INFARCT ( RED INFARCT)
34
 where bleed occurs 
into the necrotizing cerebral tissue. Pathogenesis of hemorrhagic infarct is 
explained by 2 mechanisms
35
- 
(i) Reperfusion of the ischemic tissue following spontaneous lysis 
of the embolus 
(ii) In persistent occlusion of the vessel proximally, due to 
reperfusion from leptomeningeal vessels that form the collateral 
circulation. 
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 Probability of hemorrhagic infarction depends on the size of the 
infarct, extent of collateral circulation and the use of anticoagulant and 
thrombolytic agent. 
 SMALL VESSEL STROKE 
 LACUNAR  INFARCTION 
 Caused by occlusion of small penetrating arteries  
 Involves the 30-300µm branches of the major cerebral arteries that 
penetrate the deep gray and white matter of the cerebrum or 
brainstem. 
 Occlusion by atherothrombotic disease or lipohyalinotic thickening 
 Small infarcts 3mm to 2cm diameter called lacunes 
 Risk factors : Hypertension, age 
 Pure motor stroke : 33-50% of all small vessel strokes 
 A large vessel stroke may initially manifest as a lacunar syndrome  
 Lacunar syndromes referable to posterior circulation31  
o Hemiballism 
o Hemichorea 
o Isolated dysarthria 
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LACUNAR  SYNDROME SITE  OF  INFARCT 
PURE MOTOR HEMIPARESIS POSTERIOR LIMB OF INTERNAL 
CAPSULE / BASIS PONTIS 
PURE SENSORY STROKE VENTRAL THALAMUS 
ATAXIC HEMIPARESIS VENTRAL PONS / INTERNAL 
CAPSULE 
DYSARTHRIA AND CLUMSY 
HAND SYNDROME 
VENTRAL PONS / GENU OF 
INTERNAL CAPSULE 
Table 2: Lacunar syndromes 
GLOBAL  ISCHEMIA/ HYPOTENSIVE STROKE 
 Occurs following drastic reduction in systolic BP due to any cause.  
 Cerebral gray matter is particularly vulnerable 
 The more susceptible neurons are the Purkinje cell layer of 
Hippocampus and Purkinje cell layer of the cerebellar cortex. 
 Abundance of glutamate makes them more susceptible to global 
ischemia 
 Global ischemia causes maximum damage to areas between the 
terrirories of the major cerebral and cerebellar arteries called the 
‘Boundary Zone’ or ‘Watershed Area’. 
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Watershed Infarct 
o Develops in the region between the adjacent arterial territories 
which share a collateral circulation 
o Parietotemporooccipital triangle at the junction of anterior, middle 
and posterior cerebral arteries is most commonly affected
36
. 
o Results in paralysis and sensory loss of the arm sparing the face 
and speech 
o Comprises 10% of ischemic strokes 
o 40% occur in carotid stenosis/occlusion 
Borderzone/ Terminoterminal Infarcts
37 
          Occurs between two arterial territories whose parent vessels do not 
share a collateral flow   
STROKE  DUE  TO  UNDETERMINED  CAUSE 
 Includes cases where complete workup and screening for cardiac 
conduction/ structural abnormalities, intracranial/ extracranial large 
artery occlusions, coagulopathies and other underlying conditions has 
been nonconclusive.  
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 Clinical situation where complete workup cannot be done is also 
included in this. 
  Since they form a large share of strokes, newer subclassifications like 
ASCO and computer-aided SSS-TOAST have been proposed to study 
their outcomes and riskfactors
38
. 
CONDITIONS  THAT  MIMIC  TIA / STROKE  
o Migraine  
o Seizure  
o Hypoglycemia  
o Brain tumor 
o Arteriovenous malformation 
o Multiple sclerosis 
o Incipient syncope  
o Orthostatic hypotension  
o Cardiac arrhythmia 
o Amnesia 
o Narcolepsy/cataplexy 
o Intracranial inflammation( Meningitis/ Encephalitis)  
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o Periodic paralysis 
o Compressive neuropathy  
o Dizziness of uncertain cause 
o Anxiety 
o Hyperventilation 
o Labyrinthine disease 
RISK  FACTORS  FOR  STROKE 
 Definite 
 Modifiable : Cigarette smoking 
Excessive alcohol consumption 
Drug use (cocaine, amphetamines) 
 Non modifiable : Age 
                                       Sex 
                                       Race 
                                       Familial and genetic factors 
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 Possible 
 Oral contraceptive use 
 Diet 
 Personality type 
 Geographic location 
 Season 
 Climate 
 Socioeconomic factors 
 Physical inactivity 
 Obesity 
 Abnormal blood lipids 
 Disease or disease markers 
 Hypertension 
 Cardiac disease 
 TIA 
 Elevated hematocrit 
 Diabetes mellitus 
 Sickle cell disease 
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 Elevated fibrinogen concentration 
 Migraine headaches and migraine equivalents 
 Carotid bruit 
 
RISK  FACTOR RELATIVE  RISK 
HYPERTENSION 2-5 
ATRIAL FIBRILLATION 1.8-2.9 
DIABETES 1.8-6 
SMOKING 1.8 
HYPERLIPIDEMIA 1.8- 2.6 
ASYMPTOMATIC CAROTID STENOSIS 2.0 
Table 3 : Risk factors of ischemic stroke 
HYPERTENSION 
 Major risk factor for ischemic stroke 
 Present in 50-70% of cases 
 There is association between blood pressure and risk of stroke even 
at a systolic BP of 115mmHg 
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DIABETES 
 Clear risk factor for 1st stroke 
 Independent risk factor for recurrent stroke 
 Predictor of multiple lacunar infarcts 
DYSLIPIDEMIA 
 Increased levels of total cholesterol and LDL-C are associated with 
higher risk of ischemic stroke
39
 
 High serum triglyceride is independently associated with ischemic 
stroke especially large artery atherosclerotic strokes
40
 
 Reduced HDL-C is also associated with greater risk of ischemic 
stroke 
SMOKING 
 Major independent risk factor for ischemic stroke 
 Risk of stroke is also increased in exposure to passive smoking and 
tobacco smoke in the environment
41
. 
 Smoking facilitates atherosclerosis 
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 5years after smoking cessation, stroke risk of ex-smoker is equal to 
that of nonsmoker 
ALCOHOL 
 Chronic alcoholism and heavy drinking bear a high risk for all 
stroke subtypes 
 Studies have shown that there is a J shaped association between 
alcohol and ischemic stroke with the effect that there is protective 
effect in light or moderate consumption to increased risk in heavy 
consumption. 
 The protective effect is due to raised HDL, decreased platelet 
aggregation and reduced concentration of plasma fibrinogen 
 Increased risk is attributed to alcohol induced hypertension , 
hypercoagulable state, reduced cerebral blood flow and atrial 
fibrillation or cardioembolism due to cardiomyopathy 
 Also plays a role in insulin resistance and metabolic syndrome. 
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OBESITY 
 Body Mass Index > 30kg/m2  is by itself a risk factor for 
cardiovascular disease 
 Major role in primary prevention 
 There are no studies to support that weight reduction may reduce 
the risk of recurrent stroke. 
PHYSICAL  ACTIVITY 
 Exerts beneficial effect on various risk factors for stroke 
 Physical activity reduces blood pressure and weight, enhances 
vasodilatation, improves glucose tolerance and promotes 
cardiovascular health. 
METABOLIC  SYNDROME 
 Combination of several physiological abnormalities that increase 
risk of stroke. 
 According to American Heart Association criteria, metabolic 
syndrome is recognized when 3 out of 5 features are present 
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(i) Increased waist circumference ( >102cm in men and >88cm in 
women) 
(ii) Increased triglycerides ( >150mg/dl) 
(iii) Decreased HDL-C (<40mg/dl in women and <50mg/dl in men) 
(iv) Increased blood pressure ( systolic >130mmHg or diastolic  
>85mmHg) 
(v) Increased fasting blood glucose ( >100mg/dl) 
 Research has redefined the syndrome so as to include subclinical 
inflammation and disorders of thrombosis, fibrinolysis and 
endothelial function and theories suggest that it may be 
transmitted genetically
42
. 
HEART DISEASE 
 The basic pathology being the same, if the coronaries are diseased, 
arteries to the brain are also likely to be affected 
 Coronary artery disease, congestive heart failure, left ventricular 
hypertrophy, valvular heart disease and arrhythmias are all 
associated with graeter risk of stroke. 
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AGE 
 Risk of stroke significantly increases with age 
 The risk of stroke with advancing age cannot be changed, it has a 
prime role in assessing stroke risk and planning preventive 
therapies. 
ORAL  CONTRACEPTIVE  PILLS 
 Oestrogen promotes blood clotting 
 Low dose oestrogen minimizes this risk 
CAROTID  BRUIT 
 Noise due to turbulent flow in a blood vessel (artery) as a 
consequence of narrowing due to atherosclerosis 
 Associated with high risk of ischemic stroke 
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INVESTIGATIONS 
o Basic Investigations : Complete blood count 
                                      Erythrocyte sedimentation rate 
                                      Serum electrolytes 
                                      Blood urea nitrogen 
                                     Serum creatinine 
                                     Blood sugar 
                                    Urine analysis 
                                    Serum lipid profile 
o Electrocardiogram 
o Chest Xray 
o Coagulation profile : Prothrombin time 
                                     Activated partial thromboplastin time 
o Echocardiogram  
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o IMAGING  STUDIES 
 CT SCAN 
 Imaging modality of choice in acute stroke 
 Early identification or exclusion of hemorrhage  
 Identification of extraparenchymal hemorrhages, 
neoplasms, abcesses and other conditions mimicking 
stroke 
 Infarct may not be seen reliably for 24 to 48 hours 
 Small ischemic strokes in the posterior fossa are not seen. 
 Small infarcts on the cortical surface are missed. 
 CONTRAST ENHANCED CT SCAN 
 Picks up subacute infarcts 
 Allows visualization of venous structures 
 Highlights the deficits in brain perfusion and shows 
regions of infracted brain as well as ischemic penumbra 
 Carotid disease and intracranial vascular occlusions are 
picked up with CT angiography 
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 MRI SCAN 
 Reliably detects the extent and location of infarct in all areas 
of brain including posterior fossa and cortical surface 
 Less sensitive to detect acute bleed 
 Diffusion weighted imaging more sensitive for early brain 
infarction 
 MR perfusion studies using Gadolinium contrast pick up 
ischemic penumbra 
 MR angiography detects stenosis of extracranial internal 
carotid arteries and large intracranial arteries with high 
sensitivity. 
 MRI with fat saturation visualizes extra or intracranial 
arterial dissection 
 After the acute period, MRI clearly defines the extent of 
tissue injury and demarcates areas of old infarction from 
new. 
 Highly sensitive to identify areas of new infarction in 
transient ischemic attacks 
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 CONVENTIONAL  XRAY  CEREBRAL  ANGIOGRAPHY  
 Considered gold standard in identifying and quantifying 
stenosis of cerebral arteries due to atherosclerosis 
 CT angiography of entire head and neck may be used in 
the initial evaluation of stroke. 
 Also identifies aneurysms, vasospasm, intraluminal 
thrombi, arteriovenous fistula, vasculitis, fibromuscular 
dysplasia and collaterals 
 Drawbacks : 
 Arterial damage 
 Groin hemorrhage 
 Embolic stroke 
 Contrast nephropathy 
 Conventional angiography coupled with endovascular 
techniques is employed in cerebral revascularization 
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 ULTRASOUND  TECHNIQUES 
 B mode ultrasound imaging is coupled with Doppler 
ultrasound for flow assessment ( Duplex ultrasound) 
 Identifies and quantifies stenosis at origin of 
internal carotid artery 
 Transcranial Doppler 
 Assesses flow in middle cerebral artery, anterior 
cerebral artery, posterior cerebral artery and 
vertebrobasilar system. 
 Combination of MR angiography with these ultrasound 
studies used in evaluating vascular stenosis 
 PERFUSION  TECHNIQUES 
 Xenon CT and PET  
 Assess and quantify cerebral blood flow 
 Help in the planning of revascularization surgeries 
 Single photon emission computed tomography (SPECT) 
 Measures relative cerebral blood flow 
  
47 
 
 CT  perfusion imaging 
 When combined with non contrast CT scan, detects 
ischemia and ischemic penumbra with increased 
sensitivity  
 MR perfusion imaging 
 Demarcates the ischemic penumbra when 
combined with MR diffusion imaging 
TREATMENT 
Immediate Goal : Ensuring perfusion to the ischemic penumbra 
Later Goals : Minimising disability 
                       Preventing complications  
                        Preventing recurrence 
A. MEDICAL  SUPPORT 
 Blood pressure 
 Acute blood pressure lowering controversial as collateral 
blood flow is blood pressure dependent 
 Indications for blood pressure lowering 
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 Malignant Hypertension 
 Concomitant myocardial ischemia 
 BP > 185/110mmHg 
 Planning for thrombolytic therapy 
 Fever 
 Detrimental  
 Treated with antipyretics and surface cooling 
 Serum Glucose 
 Maintained at <110mg/dl 
 Insulin infusion used if necessary 
 Cerebral Oedema  
 Peaks on 2nd or 3rd day 
 Causes mass effect for near 10 days 
 More likely with larger infarcts 
 Treated with fluid restriction and IV mannitol which raise 
serum osmolarity 
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 Hypovolemia to be avoided as the resulting hypotension 
may worsen the infarction 
 Trials have shown that hemicraniectomy markedly 
reduces mortality 
 Cerebellar Infarction 
 Even small amounts of cerebellar oedema can 
severely raise the intracranial pressure 
 Cerebellar oedema may directly compress the 
brainstem causing coma and respiratory arrest 
 Emergency surgical decompression may be 
required 
 Prophylactic suboccipital decompression of large 
cerebellar infarcts  is practiced in stroke centers  
 Infections  
 Pneumonia, urinary tract infections and bedsores are the 
common ones encountered 
 Prevented by avoiding aspiration, physiotherapy and 
prophylactic antibiotics when required 
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 Use appropriate antibiotics when needed 
 Deep Vein Thrombosis and Pulmonary Embolism 
Prevented using : 
 Pneumatic compression stockings 
 Subcutaneous heparin 
B. INTRAVENOUS  THROMBOLYSIS 
 INDICATIONS 
o Clinical diagnosis of ischemic stroke 
o Onset of symptoms to time of drug administration 
≤3hours 
o CT scan showing no hemorrhage or oedema of > 1/3rd of 
the MCA territory 
o Age  ≥ 18years 
o Consent by the patient or surrogate 
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 Contraindications  
o Sustained BP > 185/110mmHg despite treatment 
o Platelet < 1,00,000 
o Hematocrit < 25% 
o Glucose <50 or >400mg/dl 
o Use of heparin within 48hours and prolonged PTT or 
elevated INR 
o Rapidly improving symptoms 
o Prior stroke or head injury within 3months 
o Prior intracranial hemorrhage 
o Major surgery in preceeding 14days 
o Minor stroke symptoms 
o Gastrointestinal bleeding in preceeding 21days 
o Recent myocardial infarction  
o Coma or stupor 
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C. ENDOVASCULAR  TECHNIQUES 
 Intraarterial administration of thrombolytic agent  
 For large clots in the major vessels which fail to open 
with thrombolysis 
 Not yet approved by US FDA 
 Endovascular Mechanical Thrombectomy 
Indications : 
 Ineligible or with contraindications to thrombolytics 
 Failed vascular recanalisation with IV thrombolytics 
D. ANTITHROMBOTIC  TREATMENT 
 Platelet Inhibitors 
 Aspirin is the only antiplatelet drug proved to be effective 
in acute ischemic stroke 
 Use of aspirin within 48hours of stroke onset decreases 
risk of stroke recurrence and mortality 
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 Abciximab, a glycoprotein IIb/IIIa receptor inhibitor, 
should be avoided in acute stroke as it causes intracranial 
hemorrhage. 
 Anticoagulation  
 The routine use of heparin or other anticoagulants in 
atherothrombotic stroke is not supported by trials. 
E. NEUROPROTECTION 
 Measures that attempt to prolong the brain’s tolerance to 
ischemia 
 Hypothermia 
 Drugs that block excitatory amino acid pathways 
F. STROKE CENTERS 
 A dedicated stroke team improves neurologic outcome and 
reduces mortality 
 Emergency 24hour evaluation of patients with acute stroke and 
considering thrombolysis or endovascular treatments 
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G. REHABILITATION 
 Includes early physical, occupational and speech therapy 
 Involves educating the patient and family about patient’s 
neurological deficit and on prevention of complications 
 Aims to maximize recovery 
 Restraint therapy : Immobilizing the affected side improves 
hemiparesis 
         This shows that physical therapy recruits unused neural pathways 
and the fact suggests that the human nervous system is more adaptable 
than originally thought.  
 
ALBUMIN 
Albumin  Superfamily 
 Serum Albumin 
 Vitamin D binding protein 
 Alpha Fetoprotein 
 Alpha Albumin (Afamin) 
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 Most abundant plasma protein 
 55-60% of serum protein 
 585 aminoacids which form a single polypeptide chain, with a 
deficiency of tryptophan and methionine residues and an excess of 
charged residues 
 Molecular weight : 66,500Da 
 Xray crystallography reveals tertiary structure of human albumin 
crystal  
 Heart shaped molecule 80 × 30 A0  
 Highly flexible molecule which changes shape readily 
 In solution, three domains are arranged in ellipsoid pattern forming 
low viscosity molecule 
 Resilient structure which regains shape easily in physiological 
conditions due to the presence of disulphide bridges 
 Denaturation occurs only in severe nonphysiological changes in 
temperature, pH and chemical environment 
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Figure 8: Tertiary structure of albumin 
 
Figure 9 : Structure of albumin in solution 
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ALBUMIN  METABOLISM 
             Serum albumin concentration depends on the rate of its 
production and degradation and also its distribution in the intravascular 
and extravascular compartments. The total body albumin pool is about 
3.5-5g/kg bodyweight. 42%  of this is in the plasma compartment and the 
rest is in extravascular compartment. A part of this is tissue bound and 
hence out of circulation. There is a daily loss of 120-145g of albumin into 
the extravascular space, most of which is brought back into circulation by 
lymphatic drainage. There is an intestinal loss of about 1g/day and after 
digestion, there is reabsorption of amino acids and peptides. About 70kg 
of albumin passes through the kidneys everyday, of which a few grams 
are filtered through the glomerulus. This is almost completely reabsorbed 
and finally only   10-20mg of albumin is lost through urine everyday. 
EXTRAVASCULAR  POOL  OF  ALBUMIN 
o Skin, though comprises only 18% of body weight, has 41% of total 
extravascular albumin.  
o Muscle, which forms 45.5% of body weight, contains 40% of 
extravascular albumin.  
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o Gut and liver, which constitute 2.8% and 4.1% of body weight 
respectively, have 7% and 3% of extravascular albumin 
respectively. 
o Subcutaneous tissue, which forms 8% of body weight, contains 
9% of albumin.     
o Extravascular pool has exchangeable and remote components 
o Albumin escapes into extravascular compartment across capillaries 
o Half of this occurs through continuous capillaries facilitated by an 
active transport mechanism 
o Rate of escape depends on the permeability of the vessel wall and 
the hydrostatic and oncotic pressures on both sides of the wall ( 
Starling’s law) 
o Albumin binds to the the surface receptor- ALBONDIN 
o Albondin is present in most of the capillary beds except in the 
brain 
o Bound albumin enters the vesicles in the endothelial cell and gets 
released on the interstitial side within 15seconds. 
o Rate of transfer increases on addition of long chain fatty acids, with 
cationisation and with glycosylation
43
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SYNTHESIS 
 Synthesised only by liver in humans 
 Liver can increase the synthesis to 2-2.7 times the normal 
 Secreted into portal circulation soon after manufacture 
 In healthy young adult, rate of synthesis is 194mg/kg/day, about                
12-25g/day 
 Albumin synthesis requires a suitable nutritional, hormonal and 
osmotic environment 
 Colloid osmotic pressure of the interstitial fluid surrounding the 
hepatocyte is the most important regulator of albumin synthesis 
 Requirements for synthesis : 
 mRNA for translation 
 adequate supply of amino acids, activated by binding to 
tRNA 
 ribosomal machinery for assembly 
 energy as ATP or/and GTP 
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Factors causing reduced albumin synthesis : (Table 4) 
Decreased  gene transcription 
 Trauma, sepsis 
 Hepatic disease 
 Diabetes  
 Decreased growth hormone 
 Decreased steroids 
Ribosome disaggregation Decreased nutritional intake 
 
 A decrease in gene transcription results in a decrease in mRNA 
concentration. This occurs in acute phase reactions where it is mediated 
by cytokines mainly interleukin-6 and tumour necrosis factor α.  Rate of 
albumin synthesis is controlled by the mRNA concentration available for 
action on ribosomes. mRNA content is decreased in trauma and disease 
processes. Decreased gene transcription is also seen in hepatoma cells 
and in hepatocytes damaged with carbon tetrachloride.  
 Albumin synthesis requires insulin. Decreased synthesis in diabetes 
improves with insulin supplementation. Growth hormone stimulates 
gene transcription in hepatocytes
44
.  
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           Steroids have a complex role on albumin synthesis. Combination 
of steroids with insulin or aminoacids cause increase synthesis. But 
steroids also increase albumin catabolism. 
            Fasting reduces albumin production and protein restriction 
decreases it all the more. In the early phase of protein deprivation, the 
rapid disintegration of free and bound polysomes can be reversed by 
refeeding with aminoacids especially tryptophan and ornithine. 
Tryptophan is incorporated into albumin, but ornithine is not. Prolonged 
protein deprivation causes a 50-60% decrease in the concentration as 
well as activity of mRNA. Energy is more important than amino acids 
under normal circumstances for polysome aggregation. Reduced 
synthesis in starvation is found to correct with glucose refeeding alone 
which causes polysome reaggregation
45
.   
 
DEGRADATION 
 Total daily albumin degradation is about 0.2g/kg/day 
 This constitutes about 5% of daily whole body protein turnover 
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 Most of the organs in the body are involved in the breakdown of 
albumin. 40-60% of albumin is broken down by muscles and skin. 10% 
leaks into gastrointestinal tract via stomach wall. Kidneys are 
responsible for another 10%. Though the liver has a high rate of 
metabolism, it degrades less than 15%. 
          Endothelial surface membrane scavenger receptors, gp18 and 
gp30, bind to altered, denatured albumin. This is taken up by the 
endocytotic vesicles which fuse with the lysosomes in the endothelial 
cells. Chemical modification of the circulating albumin is a signal for 
receptor-linked lysosomal degradation. 
          Chemical modification may also prevent degradation. Molecule is 
protected from breakdown by the binding of long chain fatty acids to 
albumin. In hypoalbuminemia, the ratio of long chain fatty acid to 
albumin increases and breakdown is suppressed.  
           The final products of degradation are free amino acids. These join 
the amino acid pools inside the cells and in the plasma.  
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FUNCTIONS OF ALBUMIN 
(i) MAINTAINING ONCOTIC PRESSURE 
  Albumin has higher concentration in plasma than other 
plasma proteins. It has a molecular weight of 66.5kDa. Though 
this is less than the average weight of globulin (147kDa), albumin 
has great osmotic impact. Because of the high molecular weight 
and plasma concentration, in health, albumin contributes to 80% 
of the normal oncotic pressure. 60% of this is due to the direct 
osmotic effect. Negative charge of the molecule is responsible for 
the remaining 40%. This negative charge is responsible for the 
attractive force that causes intravascular retention of positively 
charged solute particles ( Gibbs- Donnan effect).  
         Albumin, because of its large extravascular pool, water 
solubility and negative charge, has a major role in the regulation 
of tissue fluid distribution. 
(ii) BINDING OF SUBSTANCES 
         Albumin has a structure that can incorporate several 
different substances. Also the structure is flexible and bound 
substances can be buried within its structure. The charge of  the 
binding substance and the strength of binding have no correlation. 
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 Substances that bind most strongly to albumin : medium-sized 
hydrophobic  organic anions 
– long chain fatty acids, 
bilirubin, haematin 
 Substances  that bind specifically but with less affinity : Ascorbate, 
tryptophan  
 Chirality of the substance also determines the strength of binding 
 Divalent cations like calcium and magnesium bind, but monovalent 
cations do not 
 Basic drugs tend to bind to albumin 
 Endogenous substances that bind to albumin : Bile acids, 
eicosanoids, copper, zinc, 
folate, aquacobalamin  
 Secondary or tertiary carrier for substances with specific binding 
proteins : 
                Steroids, vitamin D, thyroxine 
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Drug Binding 
 Binding of the drug to albumin affects its delivery to tissues and 
also its metabolism and elimination. This also determines the free serum 
concentration of the drug. Highly bound drugs have less concentration of 
their free form in serum. Drug- albumin interactions are responsible for 
the wide interindividual variations in response to drugs. Factors like age, 
temperature, pH and ionic strength influence the drug-albumin 
interactions. These alter the number of functional binding sites and the 
competition between drugs for binding sites. Endogenous substances or 
other drugs may displace the drug from its binding site and thereby the 
distribution, pharmacological action, metabolism and excretion of the 
displaced drug are altered. 
 Binding sites on albumin are broadly classified into site I and  
site II. 
Site I : Along the long loop of subdomain IIa extending into the shorter 
 loop 
            Drugs binding to this site: Salicylates, warfarin, phenylbutazone, 
                                                          Indomethacin, digitoxin, furosemide, 
Phenytoin, chlorpropamide, pencillins 
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                                                          Dyes like sulfobromophthalein, 
iophenoxate, Methyl red, Evans blue, 
bromocresol green   
 Bilirubin 
Site II : Hydrophobic pocket of residues in subdomain IIIa  
           Substances binding to this site : L-tryptophan, thyroxine, chloride,  
 Medium- chain fatty acids,  
 Diazepam, benzodiazepines,  
 Ibuprofen, naproxen, clofibrate 
(iii) METABOLIC FUNCTION 
 Albumin causes the inactivation of certain compounds like 
disulfiram, penem group of antibiotics etc. Because of the avidity of 
binding, albumin has a role in the metabolism of substances like lipids 
and eicosanoids. Albumin stabilizes eicosanoids like prostaglandin I2 and 
thromboxane A2. It also releases arachidonic acid from macrophages and 
favours lipooxygenase activity over that of cyclooxygenase. 
 Pencillin allergy is due to irreversible coupling of pencilloyl groups 
to lysine groups in site 1.  This causes production of antibodies to drug- 
albumin complex.     
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(iv) ACID-BASE FUNCTION 
 Albumin acts as an effective buffer by its relative abundance in 
plasma as well as the presence of charged residues on the molecule. At 
physiological pH, albumin contributes to half the normal anion gap with a 
net negative charge of 19. A decrease in serum albumin of 1g/dl increases 
the standard bicarbonate by 3.4mmol/L thereby reducing the anion gap by 
3mmol/litre. 
(v) ANTIOXIDANT  FUNCTION 
 Albumin has antioxidant potential under physiological conditions. 
It scavenges the free radicals which are involved in the pathogenesis of 
various diseases. The production of oxygen free radicals by activated 
polymorphonuclear leucocytes from the enzyme myeloperoxidase is also 
inhibited by physiological solutions of human albumin. This action is due 
to the sulfhydryl groups on albumin. 
(vi)MAINTAINING  MICROVASCULAR  INTEGRITY 
 Albumin controls the stress-induced increase in capillary 
permeability. This action is brought about by the endothelial cells which 
alter the permeability of the capillary membrane by altering the nature 
and distribution of glycoproteins in the vessel wall. This may be due to 
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the negative charge of the molecule or the reduction in the size of 
channels by the albumin molecule. Albumin prevents the apoptosis of 
endothelial cells, the peak action being at physiological concentrations.  
 Albumin slows the onset and enhances the vasodilatory response to 
nitric oxide. Nitric oxide by binding to the sulfhydryl groups of albumin, 
forms stable S-nitrosothiol group which is not rapidly degraded. Thus 
albumin plays a role in the regulation of vasodilatory tone of vessels. 
(vii)ANTICOAGULANT  EFFECTS 
 Has Heparin-like action due to resemblance in the structure of 
molecules with plenty of negatively charged groups. Heparin exerts its 
anticoagulant effect by the binding of negatively charged sulphate groups 
to the positively charged groups on antithrombin III. Albumin enhances 
the neutralization of factor Xa by antithrombin III. This explains the 
negative correlation between albumin concentration and heparin 
requirement in patients on hemodialysis. This might also explain the 
hypercoagulable state occurring in nephrotic syndrome. Albumin also 
exerts an inhibitory effect on platelet aggregation both dependent and 
independent of the cyclooxygenase system. 
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ANALBUMINEMIA 
Albumin has large number of variants, about 100, based on the 
electrophoretic mobility. Only one variant, which has high affinity for 
thyroxine, is known to affect the function of albumin, thereby causing 
Familial Dysalbuminemic Hyperthyroidism
46
. 
Analbuminemia has been defined as serum albumin concentration 
of less than 1g/litre. There is a small amount of albumin in circulation 
which is adequate under normal conditions. But in times of stress, when 
the requirement shoots up, features manifest. It is a rare condition which 
may be sporadic or familial. If familial, it has autosomal recessive 
inheritance. Albumin gene is present, but genetic mutations produce 
effects which prevent translation. 
Cases usually present in adulthood. The features are: 
 Peripheral oedema 
 Lipodystrophy causing lower limb obesity 
 Fatigue 
 Hyperlipidemia without atherosclerosis 
 Reduced oncotic pressure 
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 Decrease in arterial pressure causing increased rennin 
and aldosterone concentrations. 
  Body tries to compensate for the low serum albumin by slowing 
the rate of degradation. 
ALBUMIN  IN  CRITICAL  ILLNESS 
            Critical illness brings about changes in the distribution and 
metabolism of albumin. 
CHANGES  IN  DISTRIBUTION 
                There is alteration in the distribution of albumin between the 
intravascular and extravascular compartments. The underlying pathology 
is an increased capillary leakage. There occurs endothelial dysfunction, 
causing capillary leakage and loss of proteins, inflammatory cells and 
large volumes of fluid into the interstitial space. The mediators of this 
process are : 
 Endotoxins of gram-negative bacteria 
 Cytokines – TNF-α and IL-6 
 Leukotrienes and prostaglandins 
 Complement components- C3a and C5a 
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 Vasoactive peptides like bradykinin and histamine 
 Chemokines like macrophage inflammatory protein 1α 
 This altered distribution is predominantly seen in sepsis and after 
major surgical stress. The transcapillary escape rate increases upto 300% 
in septic shock and by 100% after cardiac surgery. In sepsis, this 
improves with appropriate treatment. When albumin moves out of the 
vascular compartment, there is a resultant increase in lymphatic flow 
intravascularly. There is a 30% reduction in the total circulating and total 
exchangeable albumin pools following major surgery. This is mainly due 
to the sequestration of albumin in non-exchangeable sites like wounds, 
intestine and extra-abdominal sites. 
CHANGES  IN  METABOLISM 
 There occurs alteration in the synthesis and degradation of albumin 
resulting in a dramatic decrease in serum albumin concentration even 
early in the course of a critical illness
47
.  
Synthesis  
            In trauma, inflammation or sepsis, the acute phase response 
involves an increase in the gene transcription rate of positive acute phase 
proteins like C-reactive protein and a decreased rate of albumin synthesis. 
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 The decreased synthesis is due to reduced gene transcription which 
is mediated by IL-6 and TNFα. A sustained inflammatory response 
results in prolonged inhibition of albumin synthesis. 
Catabolism 
 The degradation rate is mass dependent. So when serum albumin 
concentration decreases, degradation rate also decreases. But in increased 
transcapillary escape of albumin, there is an increase in degradation rate. 
Vascular endothelium is thought to play a major role in the degradation of 
albumin. More of tissue exposure in the presence of increased capillary 
permeability may increase catabolism. But in myxoedema, though there 
is an expansion in the extravascular pool of albumin, there is decreased 
degradation which could be due to the tissue exposure and trapping which 
protects the albumin from degradation. 
 There is a huge difference in the kinetics of intravenous albumin 
between critically ill and healthy subjects. The point of interest in this 
aspect is that increasing the intravascular albumin concentration using 
exogenous albumin may be beneficial in critical illness.     
 Oncotic pressure is low in patients who are critically ill and this 
may be associated with increased mortality and morbidity. There are 
arguments that supplementation of albumin can increase the oncotic 
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pressure  and thereby avoid life threatening complications like pulmonary 
oedema. At the same time, there are studies which suggest that 
pulmonary dysfunction in sepsis is independent of oncotic pressure. 
 Drug- albumin interactions are altered in critical illnesses. In renal 
failure, there is accelerated loss of albumin through damaged glomeruli. 
The binding of drugs to albumin is also altered in renal failure, probably 
by changes in pH and the accumulation of compounds which compete 
with drugs for the binding sites. This results in increased free fraction of 
drugs causing enhanced drug effect in renal failure. Thus it becomes 
necessary that the free serum levels of drugs should be monitored in renal 
failure in order to avoid toxicity. 
PROGNOSTIC  VALUE  OF  SERUM  ALBUMIN  
 Serum albumin acts as an independent predictor of mortality in 
various clinical settings. Serum levels of albumin may also serve as a 
marker of subclinical disease in elderly patients. Studies in hospitalized 
patients have revealed that low serum concentration of albumin is 
associated with prolonged hospital stay, more complications and higher 
mortality. It also correlates with prolonged stay in intensive care unit, 
more ventilatory requirement and increased rate of infections. The daily 
trend of serum albumin may be used as a guide to predict the weaning 
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capability of patients on mechanical ventilation
48
. Serum albumin values 
at 24-48hours of ICU admission were found to be as good as APACHE II 
score in predicting mortality. APACHE III system takes serum albumin 
value into consideration and has better predictive value for mortality in 
critical illnesses
49
. Serum albumin, though considered a measure of 
nutrition, is not a reliable marker of nutritional status in critically ill. 
 
INTRAVENOUS  ALBUMIN  THERAPY  
 There is no proven benefit for intravenous albumin over other 
colloids in volume replacement in critically ill patients. 
           Serum albumin has a beneficial role in burns patients. In the first 
24 hours, there is a gross increase in capillary permeability with marked 
transcapillary fluid shifts. Beyond 24 hours, intravenous albumin 
promotes reabsorption of plasma. According to the Guidelines Of the 
Consensus Conference in Paris
50
, burns less than 15% of body surface 
area do not require albumin. Those involving more than 50% surface area 
require albumin right from the start of treatment. For those in between, 
albumin supplementation can wait 24 hours. 
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 Albumin therapy is also beneficial in cirrhotic patients with ascites 
who require paracentesis. Postparacentesis circulatory dysfunction which 
is the increased plasma renin activity 6 days after paracentesis is 
prevented by albumin therapy.  
LIMITATIONS    
o Injudicious use can cause fluid overload doe to plasma expansion. 
o Myocardial depression probably due to binding of calcium ions. 
o Allergic reactions- mostly to contaminants in solution or polymers 
formed during storage. 
o Viral transmission though unlikely due to prolonged heat treatment 
during preparation
51
, there is theoretical risk of Creutzfield- Jakob 
disease. 
o Expensive 
 More of research and interventional studies are required and 
several controversies to be cleared before albumin therapy becomes an 
accepted treatment modality to reduce mortality in critically ill patients. 
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MATERIALS &  METHODS 
 This observational study was conducted in Coimbatore Medical 
College over a period of  six months from December 2013 to May 2014. 
It was approved by the Ethical Committee, Coimbatore Medical College. 
 The study population comprised of 100 patients who got admitted 
in medical wards with first ever acute ischemic stroke within 72 hours of 
onset of symptoms. The patients were included in the study after getting 
informed consent either from the patient himself or from the legal 
guardian. 
Study design : Prospective study 
 Exclusion criteria :  
• Patients presenting  >72hrs after onset of symptoms 
• Previous history of stroke 
• Hemorrhagic stroke 
• Stroke due to tuberculoma, tumour or trauma 
• Subarachnoid hemorrhage 
• Patients with known renal or hepatic disease 
• Patients with fever & infections 
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Cases were defined as per WHO definition of stroke. Hypertension 
was diagnosed if there were records documenting the same or when at 
least 2 readings of blood pressure were ≥140mmHg systolic or ≥90mmHg 
diastolic after the acute phase of stroke. Coronary artery disease was 
diagnosed in the presence of ECG changes or previous records. Patient 
was considered a smoker if he had a history of smoking in the past 5 
years.    
About 212 consecutive patients who were admitted with first ever 
attack of stroke were screened to get the study population of 100. Patients 
first underwent a CT scan of the Brain to rule out hemorrhagic stroke or 
any obvious mass lesions. A detailed history was elicited followed by 
general examination, an elaborate CNS examination and relevant 
examination of other systems. Stroke severity was graded using the 
Scandinavian Stroke Scale. Blood and urine investigations were done 
including complete hemogram, blood sugar, renal function test, liver 
function test with serum proteins, lipid profile and urine routine 
examination.ECG was also taken. Cases who met the exclusion criteria 
were excluded. Patients received treatment as per Institution guidelines. 
Patients were followed up and on the 7
th
 day after onset of stroke, their 
functional status was assessed using Modified Rankin Scale either in 
person if patient still in hospital or over the phone if discharged.  
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Serum albumin levels were measured using Bromocresol Green. 
The obtained data was entered into a Microsoft Excel spreadsheet 
and analysed statistically using SPSS (Statistical Package for Social 
Sciences) (version 18). The significance of association was tested using 
Chi-square test and correlation was measured by Pearson Correlation 
Coefficient. The statistical analysis was done to find out the significance 
of association, if any, between serum albumin value at admission and the 
severity of stroke at admission as well as the functional outcome at 7 days 
and also to find out the correlation between these variables. 
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 OBSERVATION
AGE  DISTRIBUTION
AGE  GROUP
Less than 40 years
40- 60 years
60- 80 years
Above 80 years
Total 
   
             Of the 100 patients included in the study, majority were in the 40
60yrs age group. Mean age of the study group was 58.44 ± 14.42yrs.
 
 
S AND RESULTS 
 
 
Table 5 : 
 FREQUENCY
 14 
 43 
 36 
 7 
 100
 
Chart 3: 
Above 80yrs
7%
40-60yrs
43%60-80yrs
36%
Less than 
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14%
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 SEX  DISTRIBUTION
GENDER
MALE
FEMALE
TOTAL
  
    The study group had a near equal proportion of males and females 
with slight male predominance. 
 
 
 
 
Table 6: 
 FREQUENCY
 54 
 46 
 100
 
Chart 4: 
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 FREQUENCY  OF  LESIONS  IN  CT BRAIN
LESION
MCA  INFARCT
MULTIINFARCT
POSTERIOR CIRCULATION STROKE
LACUNAR  STROKE
TOTAL
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Table 7: 
 FREQUENCY
 
 
 
 
 100
Chart 5 : 
25%
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DISTRIBUTION  OF  COMORBID  CONDITIONS  IN  THE  
STUDY  POPULATION 
Table 8: 
COMORBIDITY FREQUENCY 
NIL 9 
SYSTEMIC HYPERTENSION (SHT) 34 
DIABETES MELLITUS (DM) 4 
CORONARY ARTERY DISEASE (CAD) 2 
DYSLIPIDEMIA 16 
RHEUMATIC HEART DISEASE 4 
SHT & DM 14 
SHT & CAD 3 
SHT & DYSLIPIDEMIA 5 
SHT, DM & CAD 2 
DM & DYSLIPIDEMIA 5 
SHT, DM & DYSLIPIDEMIA 1 
CAD & DYSLIPIDEMIA 1 
TOTAL 100 
 
  
   
 Systemic hypertension was found to be the most frequently 
associated comorbidity followed 
hypertension and diabetes mellitus.
 
SYSTEMIC HYPERTENSION (SHT)
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CAD & DYSLIPIDEMIA
 
 
Chart 6: 
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AGE – SEX  DISTRIBUTION  IN  THE  STUDY  POPULATION 
 
Table 9: 
 
Chart 7: 
  
             The mean age of males was 55 and that of females was 62. 
Crosstab
9 26 18 1 54
16.7% 48.1% 33.3% 1.9% 100.0%
64.3% 60.5% 50.0% 14.3% 54.0%
5 17 18 6 46
10.9% 37.0% 39.1% 13.0% 100.0%
35.7% 39.5% 50.0% 85.7% 46.0%
14 43 36 7 100
14.0% 43.0% 36.0% 7.0% 100.0%
100.0% 100.0% 100.0% 100.0% 100.0%
Count
% within SEX
% within AGE
Count
% within SEX
% within AGE
Count
% within SEX
% within AGE
Male
Female
SEX
Total
Less than
40 years 40 - 60 years 60 - 80 years
Above 80
years
AGE
Total
0
5
10
15
20
25
30
<40YRS 40-60YRS 60-80YRS >80YRS
AGE- SEX DISTRIBUTION
MALE
FEMALE
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PREVALENCE OF ADDICTIONS IN THE STUDY  POPULATION 
Table 10: 
ADDICTION FREQUENCY 
SMOKING/ TOBACCO CHEWING 35 
ALCOHOL 10 
ALCOHOL/TOBACCO 3 
NIL 52 
TOTAL 100 
  
Chart 8: 
   
  
0
10
20
30
40
50
60
SMOKING/ 
TOBACCO 
CHEWING
ALCOHOL  ALCOHOL & 
SMOKING
NIL
No. OF PATIENTS
 FREQUENCY  OF  ADDICTIONS  IN  MALES  AND  FEMALES
ASSOCIATION  OF  LESIONS  WITH  AGE
 
0
5
10
15
20
25
30
35
40
MALES
MCA Infarct
Multi-infarct
PCA/ Posterior
circulation stroke
Lacunar stroke
LESION
Total
 
 
Chart 9: 
 
Table 11: 
 
FEMALES
NIL
SMOKING/TOBACCO 
CHEWING
ALCOHOL
ALCOHOL & TOBACCO
Crosstab
12 25 12
22.6% 47.2% 22.6%
85.7% 58.1% 33.3%
0 6 8
.0% 35.3% 47.1%
.0% 14.0% 22.2%
2 1 2
40.0% 20.0% 40.0%
14.3% 2.3% 5.6%
0 11 14
.0% 44.0% 56.0%
.0% 25.6% 38.9%
14 43 36
14.0% 43.0% 36.0%
100.0% 100.0% 100.0%
Count
% within LESION
% within AGE
Count
% within LESION
% within AGE
Count
% within LESION
% within AGE
Count
% within LESION
% within AGE
Count
% within LESION
% within AGE
Less than
40 years 40 - 60 years 60 - 80 years
AGE
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4 53
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57.1% 53.0%
3 17
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0 5
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0 25
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Chart 10: 
   
 
DISTRIBUTION  OF  COMORBIDITIES  WITH  AGE 
Chart 11: 
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Chart 12: 
  
 
Chart 13 : 
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Chart 14 : 
  
 
 In young stroke ( below the age of 40), rheumatic heart disease was 
the major associated comorbidity, whereas, in older age groups, 
hypertension predominates the picture.  
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DISTRIBUTION  OF  SERUM  ALBUMIN  IN   
THE  STUDY  POPULATION 
 
Table 12: 
SERUM  ALBUMIN FREQUENCY 
NORMAL (3.5-5g/dl) 57 
LOW (<3.5g/dl) 43 
TOTAL 100 
  
Chart 15 : 
 
          There was no gross difference in the number of stroke patients 
included in the study with regard to the levels of serum albumin. 
LOW ALB
43%
NORMAL ALB
57%
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ASSOCIATION  OF  SERUM  ALBUMIN  WITH  AGE 
 
Table 13: 
 
Chart 16: 
   
 The chi-square value of 6.45 for the association between age and 
serum albumin is not significant ( p>0.05).   
Crosstab
10 25 21 1 57
17.5% 43.9% 36.8% 1.8% 100.0%
71.4% 58.1% 58.3% 14.3% 57.0%
4 18 15 6 43
9.3% 41.9% 34.9% 14.0% 100.0%
28.6% 41.9% 41.7% 85.7% 43.0%
14 43 36 7 100
14.0% 43.0% 36.0% 7.0% 100.0%
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 DISTRIBUTION  OF  SERUM  ALBUMIN  IN  MALES  AND  
FEMALES 
  
 In our study population, there was a fairly uniform distribution of 
serum albumin values with no gross difference in the number of males 
and females with normal and low albumin levels.
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ASSOCIATION  OF  MRS SCORE  AT  7DAYS  WITH 
SEVERITY  OF  STROKE (SSS SCORE) 
 
Table 14 : 
S
S
S
  
S
C
O
R
E
 
SEVERITY 
MRS  SCORE 
MILD MODERATE SEVERE DEATH TOTAL 
MILD 6 0 0 0 6 
MODERATE 17 12 7 0 36 
SEVERE 0 11 22 25 58 
TOTAL 23 23 29 25 100 
 
  In the above table, the chi-square value of 64.024 for the 
association between severity of the stroke as measured by the SSS score 
and the outcome as measured by the MRS score at 7 days is significant (p 
< 0.05). Hence we can infer that there is significant association between 
the severity of stroke at onset and the outcome at 7days. 
  
  
96 
 
ASSOCIATION  OF  SEVERITY  OF  STROKE (SSS SCORE)  
WITH  SERUM  ALBUMIN 
 
Table 15 : 
 
 In the above table, the chi-square value of 13.81 for the association 
between SSS score and serum albumin is significant (p< 0.05).  This 
implies that there is significant association between the severity of stroke 
at presentation and the serum albumin value. 
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Table 16: 
Chart 18 : 
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               The chi-square value for the association between MRS score 
and serum albumin, 48.21, is statistically significant (p< 0.05). this 
implies that the stroke outcome at 7days as measured by the Modified 
Rankin scale is significantly associated with the level of serum albumin at 
stroke onset. In our study population, 84% of deaths was in the group 
with low serum albumin values. Among the patients with low serum 
albumin values, 93% landed up with severe disability or death compared 
to 24.5% in patients with normal serum albumin. This reemphasizes the 
fact that serum albumin could be of prognostic significance in acute 
ischemic stroke. 
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CORRELATION  BETWEEN  SERUM  ALBUMIN, 
GCS SCORE,  SSS  SCORE  &  MRS SCORE 
 
Table 17: 
 
 
GCS SCORE  &  SERUM  ALBUMIN 
          The Pearson Correlation Coefficient of the correlation between 
serum albumin and the Glasgow Coma Scale score at admission, 0.612, is 
statistically significant (p<0.05). This shows that there is strong positive 
correlation between serum albumin value and the GCS at admission. So 
higher the serum albumin value, better the GCS. 
  
Correlations
1 .612** .859** -.845**
.000 .000 .000
100 100 100 100
.612** 1 .558** -.700**
.000 .000 .000
100 100 100 100
.859** .558** 1 -.865**
.000 .000 .000
100 100 100 100
-.845** -.700** -.865** 1
.000 .000 .000
100 100 100 100
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
GCS
S. ALBUMIN
SSS SCORE
MRS SCORE
GCS S. ALBUMIN SSS SCORE MRS SCORE
Correlation is significant at the 0.01 level (2-tailed).**. 
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GCS  &  SSS  SCORE 
                The correlation between GCS and SSS score has a Pearson 
Correlation Coefficient of 0.859, which is statistically significant (p 
<0.05). This implies a strong positive correlation between the GCS score 
at admission and the SSS score at admission. This means that the 
Glasgow Coma Scale and The Scandinavian Stroke Scale go hand in 
hand in measuring the severity of stroke at admission. 
GCS  &  MRS  SCORE 
            The Pearson Correlation Coefficient for the correlation between 
GCS and MRS score is -0.845 which is statistically significant (p <0.05). 
This suggests a strong negative correlation between the GCS at admission 
and the MRS score at 7days. So a higher GCS at admission is associated 
with a lower MRS score or a better outcome at 7days. 
SERUM  ALBUMIN  &  SSS  SCORE 
                 The correlation between serum albumin at admission and the 
SSS score at admission has a Pearson Correlation Coefficient of 0.558, 
which is statistically significant (p<0.05). So there is a strong positive 
correlation between the serum albumin at admission and the 
Scandinavian Stroke Scale score. A higher albumin value is therefore 
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associated with a less severe stroke, as a higher SSS score indicates a 
milder stroke. 
SERUM  ALBUMIN  &  MRS  SCORE 
                The Pearson correlation coefficient for the correlation between 
serum albumin value at admission and the MRS score, -0.700, is 
statistically significant. So there is a strong negative correlation between 
the serum albumin level at admission and the Modified Rankin Scale at 
7days. A lower MRS score indicates a milder disability and better 
outcome. Hence the higher the serum albumin level, the lower the MRS 
score and better the outcome. 
SSS  SCORE  &  MRS  SCORE 
                     The Pearson Correlation Coefficient for the correlation 
between the SSS score and MRS score is -0.865, which is statistically 
significant (p<0.05). So there is strong negative correlation between the 
SSS score at admission and the MRS score at 7days. This implies that 
higher the SSS score, lower the MRS score. That is, less severe the stroke 
at admission, better the functional outcome at 7days. 
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RESULTS 
 Of the 100 patients included in the study, 54 were males ((54%) 
 The mean age of the study population was 58.44 ± 14.42 years, the 
oldest being 85year old and youngest 29years. 
 Majority  (53%) had MCA infarct 
 Rheumatic heart disease was the major comorbidity associated with 
young stroke 
 Hypertension was the major comorbidity in older age group 
 There was no significant association between serum albumin and 
age 
 A significant association was observed between serum albumin and 
severity of stroke at presentation 
 There was strong positive correlation between serum albumin and 
the Glasgow Coma scale at admission  
 A strong negative correlation was found between serum albumin at 
admission and MRS score, indicating a strong association between 
serum albumin and the functional outcome at 7days 
 There was also significant association between the severity of 
stroke at admission and the functional outcome at 7days. 
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DISCUSSION 
Albumin has well established important functions in health. 
Animal studies have shown neuroprotective effect of albumin in ischemic 
stroke. But this has not been well studied in humans. Though there are 
quite a few studies from the western world, there are very few Indian 
studies in this regard.                                                                     
Previous studies have concluded that in ischemic stroke, serum 
albumin is an independent predictor of outcome. The study by Gariballa 
et al
52
 has observed that serum albumin concentration is a strong and 
independent predictor of mortality. Of the various markers of nutritional 
status used in this study, only serum albumin showed a significant and 
independent association with stroke outcome. Aptaker et al
53
 found that 
serum albumin concentrations at admission were significantly related to 
the rate of medical complications and functional outcome in stroke. 
Our study included 100 patients with ischemic stroke. This sample 
size was small compared to most of the multicentric studies conducted in 
the western world. But the study results were comparable to that of 
previous studies. Males comprised 54% of patients in our study which 
made the sex distribution similar to the study by Abubakar et al
54
. The 
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mean age of our patients was 58.44 ± 14.42 as compared to 57.68 ± 12.4 
in this study.  
Table 18: Comparison of mortality & outcome with other studies 
Study 
Sample 
size 
Males Mean age Mortality 
Poor 
outcome 
Dziedzic et al
55
 759 49% 68.3 12.9% 36% 
Abubakar et al 75 52% 57.68±12.4 17.3% 52% 
Idicula et al 444  70.4±14.4 13%  
Our study 100 54% 58.44±14.42 25% 54% 
 
SERUM  ALBUMIN 
STUDY POOR  OUTCOME GOOD  OUTCOME 
Dziedzic et al 3.41 3.68 
Reinhardt et al
58 
< 3.4 > 3.5 
Our  study 3.13 4.16 
 
Table 19: Comparison of S.albumin & outcome in various studies 
Our study found no significant association between serum albumin 
and age as opposed to the finding in the study by Idicula et al
56
. But the 
study by Abubakar et al supported our finding. 
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Our study revealed higher mortality and more number of patients 
with unfavourable outcome compared to the study by Dziedzic et al. This 
is probably because in the afore mentioned study, patients with SSS score 
< 25 were excluded as they would be nonambulatory.  The study by 
Reinhardt et al has found that serum albumin levels of < 3.4 are 
associated with a high mortality of about 25%. This might explain the 
high mortality observed in our study.   
Our study, as in the above mentioned studies, has come out with a 
significant association between serum albumin levels and the severity of 
acute ischemic stroke. There is also significant correlation between serum 
albumin level and the functional outcome at 7 days. We have also found 
out significant correlation between the severity of ischemic stroke at 
onset and the functional outcome at 7days.    
Albumin has been considered as a measure of health and disease. 
Malnutrition, liver disease, renal disease etc. reduce serum albumin 
concentration. Catabolic state and neuroendocrine response that follow 
stroke alter the serum albumin concentration. Malnutrition also 
downregulates protein synthesis. Nutrition is thought to be the single 
most important factor regulating albumin synthesis. Having excluded 
patients with hepatic and renal disease from the study population, the 
  
106 
 
serum albumin concentration in our study is probably a reflection of the 
nutritional status and may be causally related to the increased morbidity 
and mortality after stroke.   
A study by Mallemoggala et al
57
 has found that recurrence of 
stroke also was high in patients with low levels of albumin compared to 
patients with high levels. 
A phase 3 trial, ALBUMIN IN ACUTE ISCHEMIC STROKE 
TRIAL (ALIAS), was conducted by the National Institute of 
Neurological Disorders and Stroke (NINDS) sponsored by the University 
of Miami, to determine whether human albumin administered within 5 
hours of symptom onset improves 3month outcome of subjects with acute 
ischemic stroke. The study has been terminated but the results are not yet 
available. More nutritional intervention studies are needed to prove 
beyond doubt that improving serum albumin concentration will improve 
clinical outcome. 
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CONCLUSION 
 
 Though the risk of stroke increases with age, most of our patients 
were middle aged in the 40-60year age group. 
 Smoking and hypertension are the most common modifiable risk 
factors associated. 
 GCS is as good as SSS as a measure of stroke severity. 
 There was no significant variation of serum albumin with age or 
sex. 
 Severity of stroke at onset has a definite association with outcome. 
 Serum albumin influences both stroke severity and outcome. 
 Serum albumin being a marker of nutritional status, nutritional 
support may improve the functional outcome of acute ischemic 
stroke. 
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SUMMARY 
OBJECTIVE 
1. To measure the stroke severity at admission using Scandinavian 
Stroke Scale. 
2. To assess the functional outcome of ischemic stroke on day 7 using 
Modified Rankin Scale. 
3. To find out the association between serum albumin at admission 
and the functional outcome of ischemic stroke. 
4. To find out the correlation between serum albumin level and 
severity of ischemic stroke. 
METHODOLOGY 
o Patients admitted with first ever ischemic stroke were screened 
with the aid of investigations. 
o Those who met the exclusion criteria were omitted to obtain 100 
subjects. 
o Severity of stroke at admission was measured using Scandinavian 
Stroke Scale. 
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o Functional status on 7th day was assessed with the help of Modified 
rankin Scale 
o Statistical analysis was done to find out the association and 
correlation between serum albumin value at admission and the 
severity as well as outcome.  
RESULTS 
 Of the 100 patients included in the study, 54 were males ((54%) 
 The mean age of the study population was 58.44 ± 14.42 years, the 
oldest being 85year old and youngest 29years. 
 Majority  (53%) had MCA infarct 
 Rheumatic heart disease was the major comorbidity associated with 
young stroke 
 Hypertension was the major comorbidity in older age group 
 There was no significant association between serum albumin and 
age 
 A significant association was observed between serum albumin and 
severity of stroke at presentation 
  
110 
 
 There was strong positive correlation between serum albumin and 
the Glasgow Coma scale at admission  
 A strong negative correlation was found between serum albumin at 
admission and MRS score, indicating a strong association between 
serum albumin and the functional outcome at 7days 
 There was also significant association between the severity of 
stroke at admission and the functional outcome at 7days. 
CONCLUSION 
 Serum Albumin levels have significant association with the 
severity as well as short term functional outcome of ischemic 
stroke. 
 Improving serum albumin levels may improve the functional 
outcome of acute ischemic stroke. 
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DEPARTMENT OF MEDICINE, CMC 
PROFORMA 
STUDY OF SERUM ALBUMIN AS A PREDICTOR OF 
SHORT TERM FUNCTIONAL OUTCOME IN ACUTE 
ISCHEMIC STROKE 
 Case No : 
NAME : 
AGE/ SEX : 
IP NUMBER : 
ADDRESS : 
PHONE NUMBER : 
PRESENTING COMPLAINTS: 
o Weakness 
o Seizures  
o Giddiness 
o Unresponsiveness 
o Unsteadiness of gait 
o Deviation of angle of mouth 
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DURATION OF SYMPTOMS : 
H/o FEVER/ TRAUMA 
PAST HISTORY : 
o Prior stroke 
o Diabetes mellitus 
o Hypertension 
o Cardiac disease 
o Epilepsy 
o Tuberculosis  
TREATMENT HISTORY: 
FAMILY HISTORY: 
ADDICTIONS : 
VITALS : Pulse- Rate & Rhythm 
                 Blood Pressure 
                 Respiratory Rate 
                 Temperature 
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GENERAL EXAMINATION : 
SYSTEMIC EXAMINATION 
CENTRAL NERVOUS SYSTEM 
 Higher Mental Functions : Consciousness  
                                            Orientation 
                                            Speech 
 Cranial Nerves 
 Motor system : Tone 
                          Power 
                          Reflexes  
 Sensory system 
 Cerebellar signs 
 Meningeal signs 
GLASGOW COMA SCALE : E  V  M     Total score :    /15 
SCANDINAVIAN STROKE SCALE SCORE : 
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CARDIOVASCULAR SYSTEM 
 Apex Beat 
 Heart sounds  
 Murmurs 
RESPIRATORY SYSTEM : 
 Breath sounds 
 Added sounds 
GASTROINTESTINAL SYSTEM 
 Any tenderness 
 Liver span  
 Shifting dullness 
INVESTIGATIONS 
o Complete hemogram 
o Random Blood Sugar 
o Blood urea 
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o Serum creatinine 
o Liver function tests 
o Lipid profile 
o Serum proteins : Total : 
                            Albumin : 
o Urine routine examination : Albumin: 
                                             Casts: 
                                             Cells: 
o ECG : 
o CT scan Brain : 
o MODIFIED RANKIN SCALE SCORE : 
                                (on the 7
th
 day) 
  
  
125 
 
CONSENT FORM 
 Mr/Mrs/Ms……………………………………………………, 
…………….(relationship) of……………………………………(legal 
guardian) is being asked to be a participant in the research study titled  
“STUDY OF SERUM ALBUMIN AS A PREDICTOR OF SHORT 
TERM FUNCTIONAL OUTCOME IN ACUTE ISCHEMIC 
STROKE” in CMC Hospital, Coimbatore, conducted by  
Dr.REETA JAMES, Post Graduate Student in the Department of 
General Medicine, Coimbatore Medical College. He /she satisfies 
eligibility as per the inclusion criteria. You/legal guardian can ask any 
question you may have before agreeing to participate. 
Research Being Done 
 STUDY OF SERUM ALBUMIN AS A PREDICTOR OF SHORT 
TERM FUNCTIONAL OUTCOME IN ACUTE ISCHEMIC STROKE 
Purpose of Research 
           Aim of the study is to find out the association of serum albumin at 
admission with severity of stroke & functional outcome  on day 7. 
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Procedures involved 
.       It includes details like age,sex and history of diabetes, hypertension 
& symptoms suggestive of renal or liver disease and infection as well as 
clinical examination. 
       Investigations includes complete hemogram, renal function 
tests(blood urea, serum creatinine), blood sugar, lipid profile ,liver 
function tests, serum proteins, urine routine examination, 
electrocardiogram & CT scan Brain. 
Decline from Participation 
You have the option to decline from participation in the study existing 
protocol for your condition. 
Privacy and Confidentiality 
Privacy of individuals will be respected and any information about you or 
provided by you during the study will be kept strictly confidential. 
Authorization to publish Results   
Results of the study may be published for scientific purposes and/or 
presented to scientific groups, however you will not be identified. 
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STATEMENT OF CONSENT 
I volunteer and consent to participate in this study. I have read the 
consent or it has been read to me. The study has been fully explained to 
me, and  I may ask questions at any time. 
 
-------------------------------                           -------------------------------   
Signature /Left thumb impression                       Date 
(volunteer)   
 
--------------------------------                          -------------------------------- 
Signature of witness                                               Date 
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xg;g[jy;  gotk;; [ ; ;; [ ; ;; [ ; ; 
bgah; : 
ghypdk; :       taJ : 
Kfthp : 
 
 muR nfhit kUj;Jtf; fy;Y}hpapy; bghJ kUj;Jt 
Jiwapy; gl;l nkw;gog;g[ gapYk; khztp lhf;lh;. hPj;jh n$k;!; 
mth;fs; nkw;bfhs;Sk;  "fLikahd ,uj;jg; gf;fthjj;jpd; 
FWfpa fhy bray;ghl;L tpist[fis Kd;D}fpg;ghdhfpa rPuk; 
My;g[kpd; gw;wpa Ma;t[" Fwpj;j Ma;tpy; bra;Kiw kw;Wk; 
midj;J tptu';fisa[k; nfl;Lf; bfhz;L vdJ re;njf';fis 
bjspt[g;gLj;jpf; bfhz;nld; vd;gij bjhptpj;Jf; bfhs;fpnwd;. 
 ehd; ,e;j Ma;tpy; KG rk;kjj;Jld;/ Ra rpe;jida[lDk; 
fye;J bfhs;s rk;kjpf;fpnwd;. 
 ,e;j Ma;tpy; vd;Dila midj;J tpgu';fs; 
ghJfhf;fg;gLtJld; ,jd; Kot[fs; Ma;tpjHpy; 
btspaplg;gLtjpy; Ml;nrgid ,y;iy vd;gij bjhptpj;Jf; 
bfhs;fpnwd;. ve;j neuj;jpy; ,e;j Ma;tpypUe;J ehd; tpyfpf; 
bfhs;s vdf;F chpik cz;L vd;gija[k; mwpntd;. 
 
,lk;  :      ifbahg;gk; / nuif 
ehs; : 
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MASTER CHART 
Sl.No. NAME AGE SEX LESION GCS 
S. 
ALBUMIN 
SSS 
SCORE 
STROKE 
SEVERITY 
MRS 
SCORE 
DISABILITY 
 COMORBID 
CONDITIONS 
ADDICTIONS 
1 ACHIATHAL 70 F 1 5 4.2 6 SEVERE 6 DEATH A N 
2 NANJAMMAL 70 F 4 14 4.2 30 MODERATE 4 MODERATE A S 
3 KALIYAMMAL 60 F 2 11 3.6 32 MODERATE 4 MODERATE A,B S 
4 KAVERI 70 F 1 5 4.2 10 SEVERE 5 SEVERE A,B,C N 
5 SUBBULAKSHMI 55 F 1 9 3.2 14 SEVERE 5 SEVERE E N 
6 KANNAMMAL 85 F 2 6 2.6 4 SEVERE 6 DEATH D S 
7 KALIYAMMAL 63 F 2 15 4.2 26 MODERATE 4 MODERATE A N 
8 PASUPATHY 58 F 1 9 4.1 20 SEVERE 5 SEVERE E N 
9 PAPPATHY 85 F 1 5 3.8 2 SEVERE 6 DEATH A,C N 
10 SELVI 37 F 1 7 2.7 12 SEVERE 6 DEATH F N 
11 SABIYABEE 80 F 2 13 4.6 46 MILD 1 MILD B N 
12 DHANALAKSHMI 70 F 1 12 4 48 MILD 2 MILD D N 
13 LAKSHMI 40 F 1 5 3 2 SEVERE 6 DEATH F N 
14 VIJAYALAKSHMI 57 F 1 15 4.2 49 MILD 1 MILD E N 
15 KALPANA 41 F 1 9 4.8 15 SEVERE 4 MODERATE E N 
16 MANICKAM 50 M 1 9 3 15 SEVERE 5 SEVERE A S 
17 KARUPPUSAMY 83 M 1 5 2.7 2 SEVERE 6 DEATH D S 
18 SANKARAPPAN 60 M 1 8 3.4 10 SEVERE 5 SEVERE A N 
19 MURUGAN 65 M 1 9 4 11 SEVERE 5 SEVERE A,C S,L 
20 KUMAR 39 M 3 14 4.3 42 MODERATE 3 MILD A,D S 
21 AKBAR ALI 50 M 1 11 3.8 24 SEVERE 4 MODERATE D L 
22 MURUGESAN 50 M 1 12 3.4 44 MILD 2 MILD A N 
23 KANTHASAMY 64 M 3 5 2.4 2 SEVERE 6 DEATH A L 
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24 BASAVANNA 45 M 2 12 4.2 33 MODERATE 3 MILD A,B S 
25 KRISHNASAMY 55 M 1 4 2.6 2 SEVERE 6 DEATH B N 
26 PHILIP 75 M 1 9 4 15 SEVERE 4 MODERATE D N 
27 SULAIMAN 60 M 1 6 4.7 16 SEVERE 5 SEVERE A,B S 
28 CHINNAPPAN 68 M 4 9 4.2 31 MODERATE 4 MODERATE A,B L 
29 SUNDARARAJ 41 M 1 5 2.7 2 SEVERE 6 DEATH A,B S 
30 VELUMANI 45 M 4 8 4.1 31 MODERATE 4 MODERATE D L 
31 MOORTHY 42 M 4 7 4.4 30 MODERATE 4 MODERATE A S 
32 MURUGAN 40 M 1 13 4.4 41 MODERATE 2 MILD B,D L 
33 DHANDAPANI 68 M 4 12 4.5 39 MODERATE 3 MILD D N 
34 RAJAN 45 M 4 15 4.6 46 MILD 1 MILD A N 
35 ALAGIN 79 M 4 8 3 15 SEVERE 5 SEVERE C N 
36 IYYAMMAN 45 M 1 9 2.1 42 MODERATE 5 SEVERE E S 
37 BABU 43 M 1 5 2.8 2 SEVERE 6 DEATH A S 
38 MARATHAL 70 F 1 5 3.2 2 SEVERE 6 DEATH B N 
39 JAYALAKSHMI 43 F 1 6 3 2 SEVERE 6 DEATH A,B N 
40 VALLIAMMAL 85 F 2 9 3.1 41 MODERATE 5 SEVERE A,B S 
41 SEETHALAKSHMI 70 F 4 6 3.6 2 SEVERE 6 DEATH A N 
42 RANGAMMAL 65 F 4 9 4.8 15 SEVERE 4 MODERATE A N 
43 MANICKAMMAL 84 F 1 5 3.4 2 SEVERE 6 DEATH A N 
44 MARUTHATHAL 85 F 1 5 2.6 2 SEVERE 6 DEATH E N 
45 PARVATHY 70 F 1 10 4.1 40 MODERATE 3 MILD E N 
46 PAPPAL 74 F 1 9 4.1 16 SEVERE 4 MODERATE A N 
47 VEERAMMAL 70 F 4 7 3.2 34 MODERATE 4 MODERATE A N 
48 BHAGYALAKSHMI 54 F 4 12 4.6 33 MODERATE 4 MODERATE A,B,C N 
49 PAPPATHIAMMAL 65 F 4 11 2.8 29 MODERATE 5 SEVERE A N 
50 AKBAR 59 M 4 9 4.5 39 MODERATE 1 MILD A S 
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Sl.No. NAME AGE SEX LESION GCS S. ALBUMIN 
SSS 
SCORE 
STROKE 
SEVERITY 
MRS 
SCORE 
DISABILITY 
 COMORBID 
CONDITIONS 
ADDICTIONS 
51 NAGARAJ 56 M 4 7 3.2 19 SEVERE 5 SEVERE A S 
52 SARASWATHY 57 F 1 6 3.4 14 SEVERE 5 SEVERE A,B N 
53 SURESHKUMAR 30 M 1 5 2.6 2 SEVERE 6 DEATH A,B,D S,L 
54 VIVEKANANTHAM 39 M 1 9 4 34 MODERATE 4 MODERATE D S 
55 VAIRAMUTHU 43 M 1 9 4.1 21 SEVERE 4 MODERATE B S 
56 MOHAMMED USUF 72 M 4 8 3.9 20 SEVERE 4 MODERATE A N 
57 KALAVATHY 44 F 1 5 2.2 2 SEVERE 6 DEATH B,D N 
58 MATHAYAN 60 M 3 6 3.6 4 SEVERE 5 SEVERE A S 
59 BABU 38 M 1 9 4 10 SEVERE 5 SEVERE C S 
60 AMSAVENI 34 F 1 10 4.2 30 MODERATE 5 SEVERE A,D N 
61 PHILOMINA 65 F 2 12 4.2 36 MODERATE 4 MODERATE A N 
62 AYSHABEEVI 80 F 2 5 3 2 SEVERE 6 DEATH A N 
63 HALAMMAL 70 F 2 5 2.8 2 SEVERE 6 DEATH A N 
64 CHANDRA 37 F 1 11 4.2 29 MODERATE 3 MILD F N 
65 PONNUSAMY 52 M 1 12 4.6 33 MODERATE 2 MILD A,D N 
66 ARUMUGATHAI 70 F 4 9 3.6 20 SEVERE 5 SEVERE D S 
67 THIRUMAN 72 M 2 8 3.4 12 SEVERE 5 SEVERE D S 
68 PALANIYAMMAL 60 F 4 10 4.1 23 SEVERE 4 MODERATE E N 
69 CHINNAMANI 55 F 2 11 4.2 29 MODERATE 3 MILD B,D N 
70 PAPPATHY 60 F 1 9 3.7 20 SEVERE 4 MODERATE D N 
71 MANJULA 46 F 1 9 3.8 15 SEVERE 4 MODERATE B,D N 
72 LAKSHMI 85 F 2 5 2.6 2 SEVERE 6 DEATH E N 
73 NAGENDRAN 57 M 4 10 4 26 MODERATE 4 MODERATE A,B L 
74 NEHRU 42 M 2 13 4.2 38 MODERATE 3 MILD A,C S 
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75 GOPAL 40 M 3 14 4.8 41 MODERATE 2 MILD D S 
76 VANAJA 50 F 4 9 3.1 14 SEVERE 5 SEVERE A N 
77 PETHAI 60 F 2 6 4 24 SEVERE 5 SEVERE A S 
78 VIJAYA 60 F 1 6 3.4 14 SEVERE 5 SEVERE A,B N 
79 SUBBAN 60 M 1 10 3.1 30 MODERATE 4 MODERATE A S 
80 GANAPRAKASH 40 M 1 13 4.2 39 MODERATE 3 MILD A,B S 
81 KUPPUSAMY 63 M 1 9 3 32 MODERATE 5 SEVERE A,D L 
82 RAMAIAH 68 M 4 5 2.4 2 SEVERE 6 DEATH A,B N 
83 RAYAPPAN 64 M 1 6 2.1 4 SEVERE 5 SEVERE A N 
84 THAVASUMUTHU 67 M 4 4 2.2 2 SEVERE 6 DEATH A S 
85 CHELAMANI 45 M 1 13 4 41 MODERATE 3 MILD C,D N 
86 SUBBAIAH 75 M 1 7 3.7 24 SEVERE 5 SEVERE A L 
87 THANGAVEL 63 M 3 9 4.2 21 SEVERE 4 MODERATE D S 
88 MURALIDHARAN 35 M 1 11 2.8 29 MODERATE 5 SEVERE B,D S 
89 VELUMAYIL 60 M 2 5 3 2 SEVERE 6 DEATH A S,L 
90 RANGASAMY 72 M 4 8 2.1 30 MODERATE 5 SEVERE A,B S 
91 NAMMALVAR 67 M 4 12 4.6 40 MODERATE 3 MILD A L 
92 AMOSE 53 M 1 14 4.4 41 MODERATE 3 MILD D S 
93 ASHOKRAJ 29 M 1 12 4 39 MODERATE 3 MILD A,D S 
94 KANDAN 50 M 4 12 4.1 41 MODERATE 3 MILD D S 
95 VISWANATHAN 65 M 1 10 3 16 SEVERE 5 SEVERE A,B L 
96 MUTHAN 75 M 2 4 4 2 SEVERE 6 DEATH D S 
97 SHANTHI 35 F 1 14 4.4 43 MILD 2 MILD F N 
98 BALASUBRAMANIAM 52 M 1 5 2.7 2 SEVERE 6 DEATH A N 
99 KANNAMMAL 70 F 2 9 2.8 18 SEVERE 5 SEVERE A S 
100 GANDHIMATHI 55 F 4 6 3 24 SEVERE 5 SEVERE A N 
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KEY  TO  MASTERCHART 
 
1: MCA Infarct 
2: Multiinfarct 
3: PCA/ Posterior circulation stroke 
4: Lacunar stroke 
A : Systemic Hypertension 
B: Diabetes Mellitus 
C: Coronary Artery Disease 
D : Dyslipidemia 
E: Nil 
F: Rheumatic Heart Disease 
S: Smoking/ Tobacco chewing 
L: Alcohol 
N:Nil 
 
SEVERITY 
GRADING MILD MODERATE SEVERE DEATH 
MRS 0-3 4 5 6 
SSS 43-58 26-42 0-25 -- 
 
 
 
